Skip to content

intensive monitoring

OTHER2 trials

Sponsors

Universitas Padjadjaran, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Conditions

CancerDiabetes MellitusPulmonary Tuberculosis

Related Papers